Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holly Webster

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Nature Reviews. Rheumatology|November 26, 2025
Positive phase II trial of IL-17A-IL-17F-targeting nanobody sonelokimab for PsAHolly Webster
Nature Reviews. Rheumatology|July 26, 2024
UNC93B1 variants promote SLE via TLR activationHolly Webster
Nature Reviews. Rheumatology|May 11, 2026
T cells mediate tissue damage in lupus nephritisHolly Webster
Nature Reviews. Rheumatology|June 8, 2026
Anti-CD19 CAR T cell therapy promotes skin remodelling in systemic sclerosisHolly Webster
Nature Reviews. Rheumatology|June 29, 2026
Sensory nerves protect against tendon degenerationHolly Webster
Nature Reviews. Rheumatology|October 1, 2025
DADA2 as an autosomal dominant diseaseHolly Webster
Nature Reviews. Rheumatology|November 18, 2025
cPLA2 as a therapeutic target in chondrocytes for OA and IVDDHolly Webster
Nature Reviews. Rheumatology|March 3, 2025
Joint location matters for TNF inhibitor treatment in PsAHolly Webster
Nature Reviews. Rheumatology|April 2, 2025
Sex and gender matter for TNF inhibitor therapy in RAHolly Webster
Nature Reviews. Rheumatology|January 31, 2025
T cells in Sjögren diseaseHolly Webster
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Nature Reviews. Rheumatology|November 26, 2025
Positive phase II trial of IL-17A-IL-17F-targeting nanobody sonelokimab for PsAHolly Webster
Nature Reviews. Rheumatology|July 26, 2024
UNC93B1 variants promote SLE via TLR activationHolly Webster
Nature Reviews. Rheumatology|May 11, 2026
T cells mediate tissue damage in lupus nephritisHolly Webster
Nature Reviews. Rheumatology|June 8, 2026
Anti-CD19 CAR T cell therapy promotes skin remodelling in systemic sclerosisHolly Webster
Nature Reviews. Rheumatology|June 29, 2026
Sensory nerves protect against tendon degenerationHolly Webster
Nature Reviews. Rheumatology|October 1, 2025
DADA2 as an autosomal dominant diseaseHolly Webster
Nature Reviews. Rheumatology|November 18, 2025
cPLA2 as a therapeutic target in chondrocytes for OA and IVDDHolly Webster
Nature Reviews. Rheumatology|March 3, 2025
Joint location matters for TNF inhibitor treatment in PsAHolly Webster
Nature Reviews. Rheumatology|April 2, 2025
Sex and gender matter for TNF inhibitor therapy in RAHolly Webster
Nature Reviews. Rheumatology|January 31, 2025
T cells in Sjögren diseaseHolly Webster
Pageof 4